However, it is worth noting that breast cancers in female BRCA2 mutation carriers frequently show a lobular morphology [13], thus suggesting differences in the pathogenic mechanisms of male and female BRCA2 breast cancer. This evidence concerns the gene BRCA2 and breast carcinoma.